title: Progression rate of neurological deficits in a 10-year cohort of SCA3 patients.
abstract: Spinocerebellar ataxia 3 is an untreatable CAG repeat expansion disorder whose natural history is not completely understood. Our aims were to describe the progression of neurological manifestations in a long-term cohort of spinocerebellar ataxia 3, and to verify if CAG expanded repeat, gender, and age at onset were associated with the rate of progression. Patients entered the study between 1998 and 2005 and were seen until 2007. On each visit, the validated NESSCA scale, an inventory of 18 neurological manifestations, was applied. Scores observed in each year of disease duration produced a Growth Curve, which was analyzed through the random coefficients model. Scores obtained in some individual items were described through multi-state Markov models. One hundred fifty-six patients (78 families) were recruited; 28 were lost, and 23 died. Mean (sd) ages at onset and at baseline were 32.8 (10.6) and 40.7 (12.8) years; median (range) expanded CAGn was 74 (67-85). Three hundred fifteen NESSCA evaluations were performed, comprising disease durations from zero to 34 years. The 105 patients who completed the study were seen over 5 (sd = 2.4) years at intervals of 2.5 (sd = 1.5) years. The trajectory of NESSCA obtained for the overall group increased by 1.26 points per year. This slope increased by 0.15 points per each additional CAG in the expanded repeat (p < 0.0002) and decreased by 0.03 points per each additional year of age at onset (p = 0.005). NESSCA worsened steadily, producing linear trajectories, which were faster among patients with longer expanded repeats (>74) and with lower ages at onset (<34 years).
authors.affiliation: Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. ljardim@hcpa.ufrgs.br
authors.forename: Laura Bannach
authors.initials: LB
authors.lastname: Jardim
authors.forename: Lisiane
authors.initials: L
authors.lastname: Hauser
authors.forename: Christian
authors.initials: C
authors.lastname: Kieling
authors.forename: Jonas Alex Morales
authors.initials: JA
authors.lastname: Saute
authors.forename: Renan
authors.initials: R
authors.lastname: Xavier
authors.forename: Carlos Roberto Mello
authors.initials: CR
authors.lastname: Rieder
authors.forename: Thais Lampert
authors.initials: TL
authors.lastname: Monte
authors.forename: Suzi
authors.initials: S
authors.lastname: Camey
authors.forename: Vanessa Bielefeld Leotti
authors.initials: VB
authors.lastname: Torman
mesh_terms: D000328:Adult; D000367:Age Factors; D017668:Age of Onset; D002648:Child; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D017827:Machado-Joseph Disease / Q000235:genetics* / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018911:Trinucleotide Repeats / Q000235:genetics
references.citation: Nat Genet. 1993 Jul;4(3):300-4
references.pmid: 8358439
references.citation: J Neurol. 2003 Feb;250(2):207-11
references.pmid: 12574952
references.citation: Stat Med. 1998 Oct 30;17(20):2395-403
references.pmid: 9819835
references.citation: Eur J Neurol. 2008 Apr;15(4):371-6
references.pmid: 18312406
references.citation: Mov Disord. 2009 Jul 15;24(9):1387-90
references.pmid: 19441132
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):132-40
references.pmid: 19415691
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):439-46
references.pmid: 17948873
references.citation: Brain. 1997 Dec;120 ( Pt 12):2141-8
references.pmid: 9448569
references.citation: Ann Hum Genet. 2008 Jan;72(Pt 1):57-64
references.pmid: 17683516
references.citation: J Neurol Sci. 1997 Feb 12;145(2):205-11
references.pmid: 9094050
references.citation: J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):534-6
references.pmid: 9343141
references.citation: Arch Neurol. 2001 Jun;58(6):899-904
references.pmid: 11405804
references.citation: Ann Neurol. 1995 Oct;38(4):684-7
references.pmid: 7574470
references.citation: Brain. 1998 Apr;121 ( Pt 4):589-600
references.pmid: 9577387
references.citation: Ann Neurol. 1997 Dec;42(6):924-32
references.pmid: 9403486
references.citation: Neurology. 1998 Dec;51(6):1603-7
references.pmid: 9855509
references.citation: Ann Neurol. 1996 Apr;39(4):490-9
references.pmid: 8619527
references.citation: Nat Genet. 1994 Nov;8(3):221-8
references.pmid: 7874163
references.citation: Neuroepidemiology. 2010;34(3):163-70
references.pmid: 20130417
references.citation: Clin Genet. 2007 Dec;72(6):543-5
references.pmid: 17894834